STOCK TITAN

Director James Friedlich receives 33,602-share stock grant at DHI Group (NYSE: DHX)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Friedlich James reported acquisition or exercise transactions in this Form 4 filing.

Director James Friedlich of DHI GROUP, INC. received an equity grant of 33,602 shares of Common Stock as a compensation-related award. The grant was made at $0.00 per share and is structured as restricted stock that vests on May 14, 2027.

Following this award, Friedlich directly holds 468,716 shares of DHI Group common stock. This is a non-market transaction, reflecting stock-based compensation rather than an open-market purchase or sale.

Positive

  • None.

Negative

  • None.
Insider Friedlich James
Role null
Type Security Shares Price Value
Grant/Award Common Stock 33,602 $0.00 --
Holdings After Transaction: Common Stock — 468,716 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Restricted stock grant 33,602 shares Equity award to director on May 14, 2026
Grant price $0.00 per share Indicated price for the restricted stock award
Total holdings after grant 468,716 shares Director’s direct DHI Group common stock ownership post-transaction
Vesting date May 14, 2027 Vesting date for the 33,602 restricted shares
restricted stock financial
"Represents a grant of restricted stock, which vests on May 14, 2027."
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
grant financial
"Represents a grant of restricted stock, which vests on May 14, 2027."
Form 4 regulatory
"INSIDER FILING DATA (Form 4):"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
Common Stock financial
"security_title": "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Friedlich James

(Last)(First)(Middle)
C/O DHI GROUP, INC.
6465 SOUTH GREENWOOD PLAZA, SUITE 400

(Street)
CENTENNIAL COLORADO 80111

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
DHI GROUP, INC. [ DHX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/14/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/14/2026A33,602(1)A$0468,716D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents a grant of restricted stock, which vests on May 14, 2027.
Remarks:
/s/ E. Jack Connolly, Attorney-in-Fact05/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did DHI Group (DHX) director James Friedlich report in this Form 4?

Director James Friedlich reported receiving a grant of 33,602 shares of DHI Group common stock. The award is in the form of restricted stock and represents stock-based compensation rather than an open-market trade in the company’s shares.

How many DHI Group (DHX) shares did James Friedlich receive and at what price?

James Friedlich received 33,602 shares of DHI Group common stock at an indicated price of $0.00 per share. This reflects a compensation grant rather than a purchase, so no cash changed hands for the awarded restricted stock.

When do James Friedlich’s new restricted DHI Group (DHX) shares vest?

The 33,602 restricted shares granted to James Friedlich vest on May 14, 2027. Until vesting, the award is subject to the applicable restrictions, after which the shares should become fully owned if vesting conditions are satisfied.

What is James Friedlich’s total DHI Group (DHX) shareholding after this grant?

After the restricted stock grant, James Friedlich holds 468,716 shares of DHI Group common stock directly. This total includes the newly awarded 33,602 shares, reflecting his updated direct ownership position reported in the Form 4 filing.

Was the DHI Group (DHX) Form 4 transaction a market buy or sell?

The Form 4 does not show a market buy or sell; it reports a grant of restricted stock coded as an acquisition (A). This is a compensation-related award, not an open-market transaction executed at prevailing trading prices.